Mr Gabriel Yap
Director of Investments and Legal, Lucence
Gabriel is the Director of Investments and Legal of Lucence. He spearheads investor relations and provides legal advice towards Lucence’s scalability and growth in its core markets. He is a former corporate counsel and brings with him experience from a listed property investment company and the Singapore Land Authority. Gabriel is called to the Singapore Bar and holds an LLB from the University of Nottingham. Lucence is a precision oncology company headquartered in California and Singapore, supplying liquid biopsy testing worldwide through a central CAP and CLIA-licensed laboratory. In line with Lucence's mission of using molecular technology to improve health worldwide, Lucence is also contributing to the COVID-19 relief effort by its development of the SAFER-Sample kit which allows non-invasive sample types like saliva to be stored and transported without the use of chilled media for up to one week.